These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1355379

  • 1. [Interferon-gamma suppresses expression of the HER-2 oncogene in ovarian cancer cells].
    Marth C, Müller-Holzner E, Zeimet AG, Greiter E, Cronauer MV, Doppler W, Eibl B, Hynes NE, Daxenbichler G.
    Gynakol Geburtshilfliche Rundsch; 1992; 32(1):31-4. PubMed ID: 1355379
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.
    Kury FD, Schneeberger C, Sliutz G, Kubista E, Salzer H, Medl M, Leodolter S, Swoboda H, Zeillinger R, Spona J.
    Oncogene; 1990 Sep; 5(9):1403-8. PubMed ID: 1699198
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines.
    Möbus VJ, Asphal W, Knapstein PG, Kreienberg R.
    J Cancer Res Clin Oncol; 1993 Sep; 120(1-2):27-34. PubMed ID: 8270604
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.
    Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB, Slamon DJ.
    Oncogene; 1994 Jul; 9(7):1829-38. PubMed ID: 7911565
    [Abstract] [Full Text] [Related]

  • 10. [Cell cycle specific expression of the HER-2/NEU oncogene in breast cancer cell lines].
    Ehrhart E, Fontaine J, Unteregger G, Blin N.
    Arch Gynecol Obstet; 1989 Jul; 245(1-4):656-8. PubMed ID: 2572201
    [No Abstract] [Full Text] [Related]

  • 11. Interferon gamma-induced reduction in erbB-2 tyrosyl phosphorylation in human ovarian carcinoma cells.
    Mishra S, Hamburger AW.
    Int J Cancer; 1994 Aug 15; 58(4):538-42. PubMed ID: 7914514
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
    Menendez JA, Papadimitropoulou A, Vellon L, Lupu R.
    Eur J Cancer; 2006 Oct 15; 42(15):2425-32. PubMed ID: 16406575
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
    Konecny G, Untch M, Arboleda J, Wilson C, Kahlert S, Boettcher B, Felber M, Beryt M, Lude S, Hepp H, Slamon D, Pegram M.
    Clin Cancer Res; 2001 Aug 15; 7(8):2448-57. PubMed ID: 11489825
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor.
    Meden H, Kuhn W.
    Eur J Obstet Gynecol Reprod Biol; 1997 Feb 15; 71(2):173-9. PubMed ID: 9138962
    [Abstract] [Full Text] [Related]

  • 20. HER-2/neu oncogene expression and proliferation in breast cancers.
    Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW.
    Am J Pathol; 1990 Jul 15; 137(1):103-11. PubMed ID: 1973597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.